Cargando…
Successful Multimodal Therapy with Intracerebral Liposomal Amphotericin B and Systemic High-Dose Isavuconazole in Proven Disseminated Aspergillosis
We report the case of a 32-year-old man receiving chemotherapeutics for an acute B-lymphoblastic leukemia who developed proven cerebral and pulmonary aspergillosis with Aspergillus flavus. Because of progressive fungal disease with neurological deterioration despite adequate systemic antifungal ther...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054323/ https://www.ncbi.nlm.nih.gov/pubmed/36983495 http://dx.doi.org/10.3390/jof9030327 |
_version_ | 1785015643056111616 |
---|---|
author | Feys, Simon Dedeurwaerdere, Franceska Lagrou, Katrien Van Lerbeirghe, Jeroen Deeren, Dries |
author_facet | Feys, Simon Dedeurwaerdere, Franceska Lagrou, Katrien Van Lerbeirghe, Jeroen Deeren, Dries |
author_sort | Feys, Simon |
collection | PubMed |
description | We report the case of a 32-year-old man receiving chemotherapeutics for an acute B-lymphoblastic leukemia who developed proven cerebral and pulmonary aspergillosis with Aspergillus flavus. Because of progressive fungal disease with neurological deterioration despite adequate systemic antifungal therapy and surgical debridement, intracerebral administration of liposomal amphotericin B was initiated at 5 mg twice weekly. This led to improvement of the cerebral infection. Surgical debridement of a pleural Aspergillus empyema was necessary, and pleural trough level of isavuconazole was found to be subtherapeutic despite adequate blood trough levels, which led us to increase the dose of isavuconazole. We conclude that intralesional amphotericin B might be beneficial at 5 mg twice weekly in cerebral aspergillosis if systemic antifungals and surgical debridement fail. In Aspergillus empyema, measurement of pleural isavuconazole trough levels should be considered. |
format | Online Article Text |
id | pubmed-10054323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100543232023-03-30 Successful Multimodal Therapy with Intracerebral Liposomal Amphotericin B and Systemic High-Dose Isavuconazole in Proven Disseminated Aspergillosis Feys, Simon Dedeurwaerdere, Franceska Lagrou, Katrien Van Lerbeirghe, Jeroen Deeren, Dries J Fungi (Basel) Case Report We report the case of a 32-year-old man receiving chemotherapeutics for an acute B-lymphoblastic leukemia who developed proven cerebral and pulmonary aspergillosis with Aspergillus flavus. Because of progressive fungal disease with neurological deterioration despite adequate systemic antifungal therapy and surgical debridement, intracerebral administration of liposomal amphotericin B was initiated at 5 mg twice weekly. This led to improvement of the cerebral infection. Surgical debridement of a pleural Aspergillus empyema was necessary, and pleural trough level of isavuconazole was found to be subtherapeutic despite adequate blood trough levels, which led us to increase the dose of isavuconazole. We conclude that intralesional amphotericin B might be beneficial at 5 mg twice weekly in cerebral aspergillosis if systemic antifungals and surgical debridement fail. In Aspergillus empyema, measurement of pleural isavuconazole trough levels should be considered. MDPI 2023-03-07 /pmc/articles/PMC10054323/ /pubmed/36983495 http://dx.doi.org/10.3390/jof9030327 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Feys, Simon Dedeurwaerdere, Franceska Lagrou, Katrien Van Lerbeirghe, Jeroen Deeren, Dries Successful Multimodal Therapy with Intracerebral Liposomal Amphotericin B and Systemic High-Dose Isavuconazole in Proven Disseminated Aspergillosis |
title | Successful Multimodal Therapy with Intracerebral Liposomal Amphotericin B and Systemic High-Dose Isavuconazole in Proven Disseminated Aspergillosis |
title_full | Successful Multimodal Therapy with Intracerebral Liposomal Amphotericin B and Systemic High-Dose Isavuconazole in Proven Disseminated Aspergillosis |
title_fullStr | Successful Multimodal Therapy with Intracerebral Liposomal Amphotericin B and Systemic High-Dose Isavuconazole in Proven Disseminated Aspergillosis |
title_full_unstemmed | Successful Multimodal Therapy with Intracerebral Liposomal Amphotericin B and Systemic High-Dose Isavuconazole in Proven Disseminated Aspergillosis |
title_short | Successful Multimodal Therapy with Intracerebral Liposomal Amphotericin B and Systemic High-Dose Isavuconazole in Proven Disseminated Aspergillosis |
title_sort | successful multimodal therapy with intracerebral liposomal amphotericin b and systemic high-dose isavuconazole in proven disseminated aspergillosis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054323/ https://www.ncbi.nlm.nih.gov/pubmed/36983495 http://dx.doi.org/10.3390/jof9030327 |
work_keys_str_mv | AT feyssimon successfulmultimodaltherapywithintracerebralliposomalamphotericinbandsystemichighdoseisavuconazoleinprovendisseminatedaspergillosis AT dedeurwaerderefranceska successfulmultimodaltherapywithintracerebralliposomalamphotericinbandsystemichighdoseisavuconazoleinprovendisseminatedaspergillosis AT lagroukatrien successfulmultimodaltherapywithintracerebralliposomalamphotericinbandsystemichighdoseisavuconazoleinprovendisseminatedaspergillosis AT vanlerbeirghejeroen successfulmultimodaltherapywithintracerebralliposomalamphotericinbandsystemichighdoseisavuconazoleinprovendisseminatedaspergillosis AT deerendries successfulmultimodaltherapywithintracerebralliposomalamphotericinbandsystemichighdoseisavuconazoleinprovendisseminatedaspergillosis |